Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01531686 · ClinicalTrials.gov registry record
Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route
A clinical trial, sponsored by Vidacare Corporation.
- Terminated
- Registry status
- 8
- Enrollment target
NCT01531686 is a clinical trial that was terminated before completion, run by Vidacare Corporation. The registered enrollment target is 8 participants.
The verdict
NCT01531686 was terminated before completion, sponsored by Vidacare Corporation.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
An observational study to determine the safety and effectiveness of Intraosseous (IO) vascular access for delivery of contrast dye for Computed Tomography (CT) examination. The hypothesis is that IO access can be safely and effectively used to deliver contrast medium for CT examination.
Interventions
- PROCEDURE Intraosseous delivery of CT contrast dye
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01531686
The ClinicalTrials.gov registry entry for NCT01531686 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vidacare Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intraosseous delivery of CT contrast dye is the first listed.
NCT01531686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01531686 about?
NCT01531686 is a clinical study titled "Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route". An observational study to determine the safety and effectiveness of Intraosseous (IO) vascular access for delivery of contrast dye for Computed Tomography (CT) examination. The hypothesis is that IO access can be safely and effectively used to deliver contrast medium for CT examination.
What is the current status of trial NCT01531686?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2012-03. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01531686?
The interventions under investigation include: Intraosseous delivery of CT contrast dye (PROCEDURE).
Who is sponsoring clinical trial NCT01531686?
This trial is sponsored by Vidacare Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.